{
  "id": 13973548,
  "title": "How AI could open new avenues in biological research",
  "url": "https://urgent.news/2026/10/12/how-ai-could-open-new-avenues-in-biological-research",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-12T14:14:40.000Z",
  "source": {
    "name": "The Indian Express",
    "slug": "the-indian-express",
    "url": "https://indianexpress.com/article/upsc-current-affairs/upsc-essentials/how-ai-could-open-new-avenues-in-biological-research-10918359/"
  },
  "original_language": "en",
  "account": "In a recent breakthrough, an AI system identified a novel enzyme system within viruses that infect bacteria, highlighting the potential for AI to open new avenues in biological research and medicine. This system, developed by Anthropic and named array-associated reverse transcriptases (ART), could have otherwise taken human researchers weeks or months to discover. This discovery, made in approximately 21 hours, signifies a shift in the field, with AI moving from a mere assistive tool to an active collaborator in scientific inquiry. While AI augments the scientific process, human oversight and intervention remain crucial to ensure transparency and accountability. In the realm of biomedical research, AI tools like NotebookLM, ResearchRabbit, and Elicit are already utilized in literature surveys, experimental planning, and citation tracking. More significantly, AI aids in processing vast biological databases, enabling researchers to identify trends and generate predictions that can guide experimental investigation. A prime example is Google DeepMind's AlphaGenome, capable of analyzing DNA sequences and predicting how variations can affect gene regulation. This is especially valuable in the study of rare and genetic diseases, where existing computational tools are limited in their ability to characterize the non-coding regions of DNA. Furthermore, AI is being employed to predict biological structures and functions, as demonstrated by Google DeepMind's AlphaFold2. This tool was instrumental in the recognition of the 2024 Nobel Prize for Chemistry and predicts protein structures based on amino acid sequences. Such advancements in AI-enabled biology hold promise for understanding protein function, disease mechanisms, vaccine design, drug development, and biomarker discovery. Looking ahead, generative AI models like Stanford University and Arc Institute's Evo2 could design entirely new biological systems, such as novel viral genomes, paving the way for innovative applications in treating antibiotic-resistant infections.",
  "summary": null,
  "key_points": [
    "AI identifies novel enzyme system in bacterial viruses within 21 hours.",
    "Anthropic's ART system could have taken human researchers weeks or months.",
    "AI tools assist in literature surveys, experimental planning, and citation tracking."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}